Catalyst Wire Dossier Catalyst Wire Dossier

AUR101

· Aurigene Discovery Technologies Limited
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for AUR101, covering 2022-12-13 to 2023-08-14. Get the full timeline:

Most recent: Clinical Trial Update: A Phase II Study to Evaluate Efficacy & Safety of AUR101 in Patients of Moderate-to-Severe Psoriasis [Phase 2]

See pricing